DOCSLIB.ORG

DBT – BIRAC Innovators Compendium: 2012

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
DBT – BIRAC Innovators Compendium: 2012 innovatorsDBT-BIRAC Impacting through innovations DBT – BIRAC INNOVATORS Department of Biotechnology PROMOTING INNOVATION FOR AFFORDABLE PRODUCT DEVELOPMENT Government of India DBT – BIRAC Innovators Compendium: 2012 In association with Biotech Consortium India Limited V Floor, Anuvrat Bhawan, 10, Deen Dayal Upadhay Marg Namaste Publication Pvt Ltd New Delhi-110002 Lakshmi Villa, 93/14, Nandidurga Road, Phones: +91 (011) 23219064-67 Benson Town, Bangalore 560 046. Fax: +91 (011) 23219063 Phone: +91-80-2353 6022/4095 8114 E Mail: [email protected] E Mail: [email protected] Web Site:www.bcil.nic.in DBT – BIRAC Innovators Compendium: 2012 Foreword DBT-BIRAC Innovators Meet-Compendium It gives me great satisfaction to note that Department of Biotechnology (DBT), Ministry of Science and Technology, Government of India and Biotechnology In- dustry Research Assistance Council (BIRAC) have through a critical due diligence process identi! ed and supported innovative nationally relevant ideas / products / processes for further development and commercialization. This support to industry innovation research through public private partnership is aimed at developing innovative technologies aimed for a" ordable product development. This compendium is an e" ort to share the highlights of these innovation ef- forts with the researchers and the Biotech Community at large. I hope that this document would facilitate knowledge networking and collaborations desirable for strengthening the capabilities of our national Biotech Sector and give us a sense of how well we are doing and what aspects need redesigning. I wish the researchers success in their endeavors towards innovation research. Dr. M. K. Bhan Secretary, DBT & Chairman, BIRAC 10 October 2012 | 3 DBT – BIRAC Innovators Compendium: 2012 List of companies in compendium List of companies in compendium Company Page No. Company Page No. A P Organics Pvt Ltd 45 Metahelix Life Sciences Pvt. Ltd. 54 Agada Medical Technologies 14 Nagarjuna Fertilizers and Chemicals Limited 60 Amar Immunodiagnostics Pvt. Ltd. 44 Neurosynaptic Communications Pvt. Ltd. 31 Anthem Biosciences Pvt. Ltd. 15 Nirmal Seeds Pvt. Ltd . 55 Bejo Sheetal Seeds Pvt Ltd 46 Panacea Biotec Ltd. 32 Bigtec Private Ltd 16 Persistent Systems 65 Biocon Ltd. 17 Rasayani Biologics Pvt Ltd 33 Cellworks Research India Pvt Ltd 18 Ravindranath GE Medical Associates Pvt. Ltd. 34 Centre for Cellular and Molecular Platforms 19 Revelations Biotech Pvt Ltd 35 (CCAMP) Richcore Lifesciences Pvt. Ltd. 61 Chromous Biotech Pvt. Ltd. 47 Rossari Biotech Limited 66 Clonz Biotech Private Limited 20 Sea6 Energy Pvt. Ltd. 62 Crystalin Research Pvt Ltd 21 Serum Institute of India Ltd. 36 Designinnova 22 Serum Institute of India Ltd 37 Frontier Lifeline Pvt. Ltd 23 SPC Biotech P Limited 63 GEO Biotechnologies India Pvt. Ltd. 48 Sphaera Pharma 28 Imgenex India Pvt. Ltd. 24 SRI Biotech Laboratories India Ltd 56 Inbiopro Solutions Pvt Ltd 25 SRI Biotech Laboratories India Ltd 57 Incozen Therapeutics Pvt. Ltd. 26 Stempeutics Research Pvt Ltd. 38 India Glycols Ltd. 59 Strand Life Sciences Pvt. Ltd. 39 Janacare Solutions Pvt. Ltd. 27 Sun Pharmaceutical Industries Ltd 40 JK Agri Genetics Ltd. 49 Tata Chemicals Ltd. 58 Kaveri Seed Company Ltd 50 Tergene Biotech Private Limited 41 Krishidhan Seeds Pvt Ltd. 51 Thermax Ltd. 64 Lifecare Innovations Pvt Ltd 29 Transasia Bio-medicals Ltd 42 Maharashtra Hybrid Seeds Company Limited 52 Vitas Pharma Research Pvt. Ltd. 43 Maharashtra Hybrid Seeds Company Limited 53 Merkel Haptic Systems Pvt Ltd 30 Foreword - 3 Preface - 5 Impact Assessment Report - 67 Introduction - 6 DBT – BIRAC Innovators Compendium: 2012 Preface DBT-BIRAC Innovators Meet-Compendium The Department of Biotechnology, under the Government of India, has been support- ing industry innovation research through various schemes such as Small Business Inno- vation Research Initiative (SBIRI), Biotechnology Industry Partnership Programme (BIPP) and the recently launched Biotechnology Ignition Grant Scheme (BIG). The e" ort has been to promote and nurture innovation research in the biotech enterprise with special focus on promoting industry academia interaction. The Contract Research and Services Scheme (CRS) launched early this year is also aimed in this direction. The recently setup Public Sector Organization of Department of Biotechnology (DBT)- Biotechnology Industry Research Assistance Council (BIRAC) aims at empowering and enabling the biotech innovation ecosystem for a" ordable product development. One of the key strategies of BIRAC is fostering innovating capabilities in all places of research, with a focus on Startups and SMEs. BIPP is a government partnership with Industries for support on a cost sharing basis for path-breaking research in frontier futuristic technology areas that have major economic potential, making the Indian industry globally competitive. It is focused on IP creation with ownership retained by Indian industry. Over the last few years through this sup- port, a large number of innovations have resulted in some important technologies and products. Nearly 100 agreements have been signed with approximately 90 di" erent companies including more than 50 startups and SMEs. Nearly 30 academic research institutes and universities are involved in collaborative projects. A total investment of US$ 150 million has been committed with approximately US$ 65m coming from Government of India and a contribution of US$ 95m coming in as private sector contribution. Through this compendium we have compiled the various innovations highlighting the uniqueness, novelty, national and societal relevance and market potential of the tech- nologies and products developed and under development. We hope this compendium would provide useful information with regard to the innovation research being conduct- ed by the Biotech Industry through Government support and we wish the researchers success in their present and future endeavors. Dr. Renu Swarup Adviser, DBT and MD, BIRAC 10 October 2012 | 5 DBT – BIRAC Innovators 2012: Introduction n -cancer compounds, immunogens against rope and DNA chips. Bacterial ropes essen ally consist of H1N1, detec on kits for autoimmune diseases, certain mutant bacteria that have the ability to grow into cheap recombinant human insulin, stem cell re- spaghe -like structures. When impregnated with certain Asearch, stress tolerant rice, enzyme produc on metal ions, these can be stronger than steel but much from agri-waste, enhancing ethanol yield, biomass pro- lighter and biodegradable. DNA chips, as part of predic ve duc on and conversion to fuel, bio-hydrogen produc on, medicine, will enable monitoring and predic ng the possi- nano pes cide manufacture - the Indian biotech industry bility of diseases, thereby ins tu ng preven ve measures is in the thick of it all. India is amongst the top-12 biotech or treatments. Gene cally engineered plants will show des na ons in the world and ranks second in Asia, a er the way towards produc on of monoclonal an bodies for China. The largest producer of the recombinant Hepa s diagnosis and therapy. All these can be developed with B vaccine in the world, India is globally recognised as a the available knowledge and skills. manufacturer of economical, high-quality bulk drugs and But for all these to happen, the country needs to invest formula ons. Scien sts believe that India can leapfrog big me in research and development (R&D). While we into the biotech future shaped by materials like bacterial know the importance of R&D, most large organisa ons in 6 | October 2012 DBT – BIRAC Innovators 2012: Introduction India are not very forthcoming in commi ng large bud- According to the data obtained from BIRAC sources, gets in R&D and prefer to buy knowhow or are happy to of the total 93 approved schemes under BIRAC-BIPP um- work as a franchisee of an original inventor from abroad. brella, there are 57 products/processes under the broad On the other hand, there are large number of small com- healthcare segment; 21 under agriculture; 3 Industrial; 9 panies and entrepreneurs, bubbling with innova ve ideas under Energy; 4 under infrastructure capacity building; but very li le fund to bank on. Fortunately, in the fi eld and one under Bio-informa cs. The range is clearly indica- of biotechnology, which has many promising sub-seg- ve of the reach of BIRAC while a look at the fi rms will ments, the government of India through the Department reveal that not only many SMEs have availed the benefi ts, of Biotechnology has extended its helping hand. The DBT, there are many big names like Biocon, Mahyco, Avestha- through several government en es, has launched many gen, Cadilla, Serum Ins tute, Bharat Biotech, Stempeu cs, schemes to foster innova ons. Strand Life Science, and others who have also got fi nan- cial assistance from BIPP. Not only is this proof of BIRAC’s Making a diff erence strengths but also of the sore need for such an agency. It is in this context that the Biotechnology Industry Re- Given the poor reach of healthcare services in India search Assistance Council (BIRAC) has been set up ex- and the huge need to make healthcare aff ordable and pressly to support innova on and provide infrastructure well penetrated for the vast popula on in the country, and services to the Indian biotechnology sector, espe- BIRAC has rightly emphasised its assistance focus. The cially the SMEs. Set up as a Sec on 25 company, BIRAC sector-wise distribu on of assisted companies indicates addresses sector needs by providing a suitable environ-
Load more

Recommended publications
  • Microalgae Cultivation Technologies As an Opportunity for Bioenergetic System Development—Advantages and Limitations
    sustainability Review Microalgae Cultivation Technologies as an Opportunity for Bioenergetic System Development—Advantages and Limitations Marcin D˛ebowski 1,* , Marcin Zieli ´nski 1 , Joanna Kazimierowicz 2 , Natalia Kujawska 3 and Szymon Talbierz 3 1 Department of Environmental Engineering, Faculty of Geoengineering, University of Warmia and Mazury in Olsztyn, 10-720 Olsztyn, Poland; [email protected] 2 Department of Water Supply and Sewage Systems, Faculty of Civil Engineering and Environmental Sciences, Bialystok University of Technology, 15-351 Białystok, Poland; [email protected] 3 InnovaTree Sp. z o.o., 81-451 Gdynia, Poland; [email protected] (N.K.); [email protected] (S.T.) * Correspondence: [email protected] Received: 19 September 2020; Accepted: 27 November 2020; Published: 29 November 2020 Abstract: Microalgal biomass is currently considered as a sustainable and renewable feedstock for biofuel production (biohydrogen, biomethane, biodiesel) characterized by lower emissions of hazardous air pollutants than fossil fuels. Photobioreactors for microalgae growth can be exploited using many industrial and domestic wastes. It allows locating the commercial microalgal systems in areas that cannot be employed for agricultural purposes, i.e., near heating or wastewater treatment plants and other industrial facilities producing carbon dioxide and organic and nutrient compounds. Despite their high potential, the large-scale algal biomass production technologies are not popular because the systems for biomass production, separation, drainage, and conversion into energy carriers are difficult to explicitly assess and balance, considering the ecological and economical concerns. Most of the studies presented in the literature have been carried out on a small, laboratory scale.
    [Show full text]
  • BIRAC Success Stories | 2016 Achira Labs
    Creating Positive Impact FOREWORDForeword cience and innovation play a key role in advancing humanity and bringing prosperity to society. Prosperous societies invest in science and nurture the entrepreneurial Senergies that can harness the fruits of science in form of innovative products. These products provide solutions to myriad challenges- from alleviating human disease conditions to helping clean the environment and bringing nutritive food on the dining table. Prof. K. VijayRaghavan Product and technology development takes time, involves huge sums of capital and is Secretary, DBT, GoI & Chairman, BIRAC riddled with risks. The role of the Government, as a catalyst, to reduce some part of this risk is a policy instrument that has been used across the world. BIRAC was established with the sole intention to imbibe a spirit of innovation in the Indian biotech sector, invest in R&D with translational goals, support startups and SMEs in biotechnology to develop products that are truly transformative- that combine affordability with high quality. India is the ‘living laboratory’ to experiment this paradigm. The products developed in India would impact not only communities in India but across the world. Success in the biotech product development endeavour in India, as exemplified in the products showcased in this report, highlight the fact that given an optimal environment, the Indian biotech industry can deliver highly innovative technologies and products that not only have a national relevance but global relevance as well. BIRAC has launched and spearheaded many national programmes such as BIG, SBIRI, BIPP and SPARSH that spur the Indian biotech enterprise to drive innovative R&D for productisation from testing their ideas to POC as well as taking it further in the product development funnel- validation, scale and commercialisation.
    [Show full text]
  • India's Technology Opportunity
    McKinsey Global Institute McKinsey Global Institute India’s technology opportunity: Transforming work, empowering people empowering work, opportunity: technology Transforming India’s December 2014 India’s technology opportunity: Transforming work, empowering people The McKinsey Global Institute The McKinsey Global Institute (MGI), the business and economics research arm of McKinsey & Company, was established in 1990 to develop a deeper understanding of the evolving global economy. Our goal is to provide leaders in the commercial, public, and social sectors with the facts and insights on which to base management and policy decisions. MGI research combines the disciplines of economics and management, employing the analytical tools of economics with the insights of business leaders. Our “micro-to-macro” methodology examines microeconomic industry trends to better understand the broad macroeconomic forces affecting business strategy and public policy. MGI’s in-depth reports have covered more than 20 countries and 30 industries. Current research focuses on six themes: productivity and growth; natural resources; labour markets; the evolution of global financial markets; the economic impact of technology and innovation; and urbanisation. Recent reports have assessed job creation, resource productivity, cities of the future, the economic impact of the Internet, and the future of manufacturing. MGI is led by three McKinsey & Company directors: Richard Dobbs, James Manyika, and Jonathan Woetzel. Michael Chui, Susan Lund, and Jaana Remes serve as MGI partners. Project teams are led by the MGI partners and a group of senior fellows, and include consultants from McKinsey & Company’s offices around the world. These teams draw on McKinsey & Company’s global network of partners and industry and management experts.
    [Show full text]
  • Pushing the Boundaries of Indian Tech Women on the Frontlines
    Pushing the Boundaries of Indian Tech Women on the Frontlines EDITED BY Nisha Holla Annapurna Mitra Pushing the Boundaries of Indian Tech: Women on the Frontlines Edited by Nisha Holla and Annapurna Mitra © 2020 Observer Research Foundation and Global Policy Journal. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical or photocopying, recording, or otherwise, without the prior permission of the publisher. Observer Research Foundation 20 Rouse Avenue, Institutional Area New Delhi, India 110002 [email protected] www.orfonline.org ORF provides non-partisan, independent analyses on matters of security, strategy, economy, development, energy and global governance to diverse decision-makers including governments, business communities, academia and civil society. ORF’s mandate is to conduct in-depth research, provide inclusive platforms, and invest in tomorrow’s thought leaders today. Language Editing: Preeti Lourdes John Cover and Design: Rahil Miya Shaikh Layout: simijaisondesigns Cover Image Source: Owl Stories /Getty/Royalty-free ISBN: 978-81-948115-8-9 Citation: Nisha Holla and Annapurna Mitra, Pushing the Boundaries of Indian Tech: Women on the Frontlines (New Delhi: ORF and Global Policy Journal, 2020). Contents Editors Note The Trailblazers Data-Centric Innovation and Digitalisation Wil l Catalyse India’s Growth - Nivruti Rai The Challenges and Opportunities of Innovating in India - Kiran Mazumdar-Shaw Transforming the
    [Show full text]
  • Pushing the Boundaries of Indian Tech Women on the Frontlines
    Pushing the Boundaries of Indian Tech Women on the Frontlines EDITED BY Nisha Holla Annapurna Mitra © 2020 Observer Research Foundation and Global Policy Journal. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical or photocopying, recording, or otherwise, without the prior permission of the publisher. Observer Research Foundation 20 Rouse Avenue, Institutional Area New Delhi, India 110002 [email protected] www.orfonline.org ORF provides non-partisan, independent analyses on matters of security, strategy, economy, development, energy and global governance to diverse decision-makers including governments, business communities, academia and civil society. ORF’s mandate is to conduct in-depth research, provide inclusive platforms, and invest in tomorrow’s thought leaders today. Language Editing: Preeti Lourdes John Cover and Design: Rahil Miya Shaikh Layout: Simijaison Designs Images: Getty ISBN: 978-81-948115-8-9 Citation: Nisha Holla and Annapurna Mitra, Pushing the Boundaries of Indian Tech: Women on the Frontlines (New Delhi: ORF and Global Policy Journal, 2020). Pushing the Boundaries of Indian Tech Women on the frontlines EDITED BY Nisha Holla Annapurna Mitra CONTENTS I. EDITORS’ NOTE 7 II. PERSPECTIVES FROM THE TRAILBLAZERS 11 Data-Centric Innovation and Digitalisation Will Catalyse India’s Growth 12 Nivruti Rai, Intel Corporation The Challenges and Opportunities of Innovating in India 16 Kiran Mazumdar-Shaw, Biocon Ltd Transforming the Biotech Innovation Ecosystem 19 Renu Swarup, Department of Biotechnology, Government of India Technology as an Enabler for Transformation 21 Vani Kola, Kalaari Capital III. EXPERIENCES FROM WOMEN ON THE FRONTLINES 1.
    [Show full text]
  • Forging India's Bioeconomy
    Burrill Media llc Life Sciences/Healthcare: Information, Intelligence, Insight FORGING INDIA’S ACCELERATING BIOECONOMY TH W GRO ABOUT THIS REPORT Burrill Media produced this report with support from the Biotechnology Industry Organization and the Association of Biotechnology Led Enterprises. © Copyright 2014 Burrill Media BURRILL MEDIA ACCELERATING GROWTH: FORGING INDIA’S BIOECONOMY FOREWARD James C. Greenwood President & CEO, Biotechnology Industry Organization Dr. P.M. Murali President, Association of Biotechnology Led Enterprises The Biotechnology Industry Organization (BIO) and the Association of Biotechnology Led Enterprises (ABLE) are pleased to provide this white paper: Accelerating Growth: Forging India’s Bioeconomy. The Indian biotechnology industry is on the cusp of entering a new era when it can provide significant economic growth and development to the people of India and around the world. India already has many of the necessary ingredients needed in order to grow its bioeconomy, such as a talented and enthusiastic scientific workforce. However, not all the ingredients are in place in order for the country to reach the next level. In 2012, ABLE laid out an ambitious goal of growing the Indian bioeconomy from its present $4.3 billion to more than $100 billion by 2025. This call to action was quickly picked up by government officials and others who saw the potential benefits of a strong and vibrant biotechnology industry in meeting the needs of Indians in regards to medicine, food, fuel, and environment. In order to reach this goal, the country needs a roadmap and this white paper is designed to provide such a guide. Biotechnology, like other industrial sectors, requires an ecosystem to nurture and sustain it.
    [Show full text]
  • Project Reference Number: I‐B/2.2/099
    Issued by Component Leader: NTUA, Date: 16/04/2013 State of the Art International Experience (WP No 1, D1.8) Project reference number: I‐B/2.2/099 MED ALGAE: The project "Production of biofuels from microalgae in selected Mediterranean Countries" is funded by the Programme ENPI European Neighbourhood and Partnership Instrument (ENPI) - Mediterranean Sea Basin Joint Operational Programme. The consortium is consisted of 12 organisations: research organizations, academic institutions, energy agencies, private organizations from 6 countries: Cyprus, Greece, Italy, Malta, Lebanon and Egypt. This is a new technology project which can contribute to the goals of the EU strategy on "Climate change and energy." The methodology includes all stages in the production of biodiesel from microalgae: sampling of seawater or freshwater, the selection of microalgae, species identification, cultivation of microalgae, harvesting and extraction of biodiesel and determination of properties of biodiesel produced in accordance with Standard EN14214 and its testing. Five pilots will be established in each participating country: Cyprus, Italy, Malta, Lebanon and Egypt. Furthermore, the project aims to collect all available data on microalgae in the participating countries (literature review and studies), to conduct a study on the available state-of-the-art technologies and also to provide feasibility studies, after implementation of research activities. The project will create a new value chain for the production of renewable liquid fuels based on microalgae, aiming transport and valuable products. The goal will be achieved through local and regional collaboration between research institutions, enterprises (SMEs) and public and private sectors. The project started in December 2011 and is expected to be finalized within 36 months.
    [Show full text]
  • International Genetically Engineered Machine (Igem) Competition Language Project
    International Genetically Engineered Machine (iGEM) Competition Language Project An educational initiative to spread the understanding of Synthetic Biology to the common public Team iGEM-IIT Madras [email protected] Language Project is an initiative by students of Department of Biotechnology at Indian Institute of Technology, Madras participating in the International Genetically Engineered Machine Competition 2018 held at Boston, Massachusetts The International Genetically Engineered Machine or ‘iGEM’ Competition is a worldwide competition in synthetic biology that began in Massachusetts Institute of Technology (MIT) in the year 2004. Within a span of 10 years, it grew from 5 teams to an independent organization in 2012 with more than 200 teams consisting of undergraduate, high school and graduate students. Teams participate in almost 10 different areas of synthetic biology such as Diagnostics, Energy, Environment, Food & Nutrition, Foundational Advance, Information Processing, Manufacturing, New Application and Therapeutics. The basic goal of the organisation is to promote the development of a society of synthetic biologists that aim at open and transparent development of tools to engineer biology for useful applications. Along with the main research based project that each team works on, they are also required to work on how their research or knowledge can impact the society. This is termed as ‘Human Practices’ and it forms a key component of the team’s judging criteria. While some teams have tried to impact the society with their own scientific research, other teams have educated the people in their country about science, engineering and biology. Some have also attempted into advising the scientific policy making bodies of their countries by creating proposals pertaining to genetic engineering and biology.
    [Show full text]
  • TRAILBLAZERS (Mapping the Journey of Young Bioentrepreneurs)
    Axio Biosolutions Pvt. Ltd. Founder: Leo Mavely Year of Establishment: 2008 Location: Ahmedabad, Gujarat Annual Turnover: Rs. 1 crore (average) Team Members: 50 Area: Molecular Therapeutics Academic Background Leo is B.Tech in applied biotechnology (bioengineering) from Maharishi Dayanand University, Rohtak and has Advanced Diploma in managing technology ventures from Nirmalabs, Ahmedabad Motivation to Pursue Entrepreneurship I always believed in indigenous development of novel healthcare products using biotechnology. While looking at this space in India, I found that advanced woundcare is quite nascent and opportunities to build a world- class brand product brand are abundant. I took a chance during my college days to pursue it and here I am Identification of Business Opportunity An incident triggered my idea for Axio. It was in 2006, when I witnessed a road accident. A bus had hit a motorbike commuter. He was bleeding profusely and I felt helpless, there was nothing I could do to stop it. Luckily I was able to take him to the hospital in time and the victim survived. I started wondering why such a basic need of a product in India that stopped such bleeding. So I started looking at projects at a tech incubator, I wanted to develop a productthat would that stop can high immediately pressure stopbleeding bleeding is not and yet give addressed. the patient I did few some more research, hours ofand a chance was unable to survive. to find I awas product working on biopolymer-based devices during my college degree and decided to pursue the search for the perfect product for a haemostat Portfolio bleeding within just 2-3 mins.
    [Show full text]
  • Fuel of the Future
    Fuel of the future 07 March 2012 | News Image not found or type unknown Algaebiofuel1Image not found or type unknown Algae as an alternative source of biofuel can be an effective answer to the escalating price of petroleum and the concern over global warming Genesis Microalgae were first mass cultured on rooftop at MIT during the early 1950s and it was in that project itself that algae biofuels were first spoken of. Between 1980 and 1995, the US DOE-NREL initiated an aquatic species program for microalgae oil production. The Technology A wide range of algae can produce lipids from solar energy, CO2 and appropriate water source. These lipids are stored in lipid vesicles as energy reserves and can comprise up to 60 percent of the dry weight of the algal cell. Both micro and macro algae appear to be a major source that can sequester high level of CO2 and can replace fossil fuels. Biodiesel production from algae is done through screening and isolation of strains with high growth rate and high oil content using various techniques. The Impact ith energy consumption increasing and the finite sources of fossil fuels With the current worldwide focus on cleaner fuels and diminishing, algal biofuels can be an alternative solution if they meet the environmental awareness, algal biodiesel is an attractive Wsame commodity standards of price, quality and service. It can prove to option. Specific production of oil per unit of biomass is be a cheaper source of biofuel as specialized algae for production of one extremely high in algae as compared to other seed million gallon of biodiesel per year requires less than 100 acres of land, crops.
    [Show full text]